guest ::
| Home > Publications database > Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. > print |
| Home > Publications database > Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. > print |
| 001 | 186457 | ||
| 005 | 20240229145746.0 | ||
| 024 | 7 | _ | |a 10.1016/j.annonc.2022.11.013 |2 doi |
| 024 | 7 | _ | |a pmid:36563965 |2 pmid |
| 024 | 7 | _ | |a 0923-7534 |2 ISSN |
| 024 | 7 | _ | |a 1569-8041 |2 ISSN |
| 024 | 7 | _ | |a altmetric:140386702 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2022-03178 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Krämer, Alwin |0 P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. |
| 260 | _ | _ | |a Amsterdam [u.a. |c 2023 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1677154780_6895 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:A360# / Volume 34, Issue 3, March 2023, Pages 228-246 |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a Classification |2 Other |
| 650 | _ | 7 | |a ESMO Clinical Practice Guideline |2 Other |
| 650 | _ | 7 | |a diagnosis |2 Other |
| 650 | _ | 7 | |a risk assessment |2 Other |
| 650 | _ | 7 | |a treatment |2 Other |
| 650 | _ | 7 | |a unknown primary neoplasm |2 Other |
| 700 | 1 | _ | |a Bochtler, T. |0 P:(DE-He78)c741dc7f974390ad4310349f29aac40b |b 1 |u dkfz |
| 700 | 1 | _ | |a Pauli, C. |b 2 |
| 700 | 1 | _ | |a Baciarello, G. |b 3 |
| 700 | 1 | _ | |a Delorme, S. |0 P:(DE-He78)3e76653311420a51a5faeb80363bd73e |b 4 |u dkfz |
| 700 | 1 | _ | |a Hemminki, K. |b 5 |
| 700 | 1 | _ | |a Mileshkin, L. |b 6 |
| 700 | 1 | _ | |a Moch, H. |b 7 |
| 700 | 1 | _ | |a Oien, K. |b 8 |
| 700 | 1 | _ | |a Olivier, T. |b 9 |
| 700 | 1 | _ | |a Patrikidou, A. |b 10 |
| 700 | 1 | _ | |a Wasan, H. |b 11 |
| 700 | 1 | _ | |a Zarkavelis, G. |b 12 |
| 700 | 1 | _ | |a Pentheroudakis, G. |b 13 |
| 700 | 1 | _ | |a Fizazi, K. |b 14 |
| 700 | 1 | _ | |a Committee, ESMO Guidelines |b 15 |e Collaboration Author |
| 773 | _ | _ | |a 10.1016/j.annonc.2022.11.013 |g p. S092375342204769X |0 PERI:(DE-600)2003498-2 |n 3 |p 228-246 |t Annals of oncology |v 34 |y 2023 |x 0923-7534 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:186457 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)c741dc7f974390ad4310349f29aac40b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)3e76653311420a51a5faeb80363bd73e |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-22 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ANN ONCOL : 2022 |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-22 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-22 |
| 915 | _ | _ | |a IF >= 50 |0 StatID:(DE-HGF)9950 |2 StatID |b ANN ONCOL : 2022 |d 2023-10-22 |
| 920 | 1 | _ | |0 I:(DE-He78)A360-20160331 |k A360 |l KKE Mol. Hämatologie/Onkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)E010-20160331 |k E010 |l E010 Radiologie |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 2 |
| 920 | 0 | _ | |0 I:(DE-He78)A360-20160331 |k A360 |l KKE Mol. Hämatologie/Onkologie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A360-20160331 |
| 980 | _ | _ | |a I:(DE-He78)E010-20160331 |
| 980 | _ | _ | |a I:(DE-He78)C020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|